| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 公司最早成立于1994年，现坐落于重庆市两江新区，是国家高新技术企业、国家创新型企业、国家智能制造新模式示范企业、国家级“绿色工厂”、市级工业设计中心，拥有国家企业技术中心及多个市级研发平台、两个制剂工厂、两个API工厂。 近30年来，华邦人一直“以优质的产品保护人类健康”为企业的愿景，致力于医药产品的研发、生产和客户服务。华邦制药已经发展成国内专业的皮肤品类服务商，同时在抗结核领域拥有较丰富的产品线。除此之外，公司还广泛涉足呼吸、心脑血管、血液、肿瘤、系统用激素等领域，蓄积了大量重磅药品，并于2021年正式推出第一个护肤品牌“三蕊”，向泛皮肤健康领域进行业务布局。公司累计取得发明专利授权200余项、注册商标520余项，被评为国家知识产权优势企业、重庆市知识产权运用示范企业，注册商标“邦力”、“必伏”、“力言卓”先后被评为“重庆市著名商标”。 未来，华邦制药将继续以市场为导向，以患者为中心，通过技术创新、高质量的产品和专业的客户服务满足用户的各类健康需求。将形成从API开发、制剂研发、临床医学研究、数字化生产到全渠道市场营销的医药类全产业链智造平台。同时积极布局皮肤养护、医美健康等非药类产品管线，着力研发泛皮肤类产品，开发能力达到国内先进水平。共同完成“满足于临床，服务于患者，忠实于人类健康”的终极职责与使命！ | ||||||||||||||||||||||||
| Main Business | 医药制剂及原料药的研发、生产和销售；收购、新设、参股等方式运营综合医疗机构和专科医疗机构，以及从事医疗配套供应链服务。 | ||||||||||||||||||||||||
| Legal Representative | 张松山 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 彭云辉 | ||||||||||||||||||||||||
| Solicitors | 北京市时代九和律师事务所 | ||||||||||||||||||||||||
| Auditors | 四川华信（集团）会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 023-67886900;023-67886985 | ||||||||||||||||||||||||
| Fax No | 023-67886985 | ||||||||||||||||||||||||
| Website | www.huapont.cn | ||||||||||||||||||||||||
| huapont@163.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 25/06/2004 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.153 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.220 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 5.104 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 8.131B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |